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InﬂammationGrowing evidence indicates thatmaternal pathophysiological conditions, such as diabetes, inﬂuence fetal growth
and could programmetabolic disease in adulthood. Placental cells, particularly Hofbauer cells (HBCs), which are
placental macrophages characterized by an anti-inﬂammatory proﬁle (M2), can sense themodiﬁedmaternal en-
vironment. The goal of this study was to investigate the direct effect of hyperglycemia on HBCs. We studied, at
mRNA and protein levels, somemarkers ofM2 andM1 (pro-inﬂammatory)macrophages in placentae from con-
trol and diabetic patients to assess the balance between pro- and anti-inﬂammatorymacrophages: an imbalance
of M2 to M1 macrophages has been observed in humans. We used pregnant rats, receiving a single injection of
streptozotocin (STZ), as a model of maternal diabetes. We noticed aM2-to-M1macrophage unbalance aswe ob-
served in human. An in vitromodel of isolated rat HBCswas used to identify the direct effects of high glucose.We
found that high glucose stimulation activated genes belonging to TLR (Toll-Like Receptor)-dependent inﬂamma-
tory pathways. Moreover, the HBCs stimulated by high glucose switched their M2 proﬁle towards M1, with in-
creased expression of pro-inﬂammatory cytokines and markers. We also noticed that the oxidative-stress
pathway was activated in response to high glucose driven by Hif-1α. In this study, we demonstrated that diabe-
tes/hyperglycemia affect the anti-inﬂammatory proﬁle of HBCs, by stimulating these cells to acquire an inﬂam-
matory proﬁle leading to adverse consequences for the fetal–placental–maternal axis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The maternal diabetic environment alters embryonic and feto-
placental development. The results of these alterations are: increased
embryo resorption and malformation rates, placental dysfunction,
fetal alterations that lead to increased neonatalmorbidity andmortality
rates, and to diseases that may develop in the later adult life of the
newborn. A successful pregnancy should not primarily be deﬁned by
outcomes at birth, but also by health status in later life. The etiology of
these many maternal diabetes-induced complications is not yet fully
understood.
The placenta is not only a maternal/fetus interface allowing
exchange between two “compartments”, but also crucial in protecting
the fetus from an adverse maternal environment. The placenta isnement Périnatal et Croissance,
n, 59045 Lille, France. Tel.: +33
ights reserved.composed of a heterogeneous population of cells that originate from
both maternal and fetal sources.
Fetal placental macrophages, or Hofbauer cells (HBCs), are present
in the villous core of the placenta [1] from the early stage of pregnancy
until full term [2]. These cells are characterized by high expression of
CD163 (a member of the scavenger-receptor cysteine-rich family of
proteins) [3]. HBCs share, with other tissue macrophages, several
functions, such as phagocytosis [4,5], transfer of serum proteins, and
tissue remodeling [6]. Moreover, previous studies report that HBCs
may regulate important processes within the placental development
[7] and that alteration to the number of HBCs is associated with
complications during pregnancy, such as villitis of unknown etiology
(VUE). [8]. In normal pregnancy, immunophenotype analyses of HBCs
shows a M2 (anti-inﬂammatory) proﬁle with increased expression of
CD163 and Il10 [9,10], in contrast to the proﬁle of M1 macrophages
(pro-inﬂammatory) Cd68 positive.
Monocytes and macrophages can respond to several environmental
stimuli [11]. Macrophages sense the hyperglycemic environment via
modulation of the expression of several isoforms of GLUT (glucose
transporters) [12]. Macrophages, in a high-glucose environment,
release pro-inﬂammatory cytokines as observed in an in vitro study
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ﬂammation, generated by macrophages, can be mediated by the
activation of Toll Like Receptors family (TLR). Activation of TLR2 and
TLR4 will start the inﬂammatory cascade via the interaction of the re-
ceptors with the adaptor molecule MyD88 (myeloid differentiation pri-
mary response 88). MyD88 recruits and activates Irak4 (Interleukin-1
receptor-associated kinase 4) and Traf6 (TNF-receptor-associated
factor-6). This pathway leads to the activation of transcription factors
like NFkB and IRF5 (interferon regulatory factor 5) and the transcription
of inﬂammation-speciﬁc genes [15].
However, no studies have focused on the effects of hyperglycemia
on HBCs. Some studies have demonstrated that diabetes, during
pregnancy, alters the expression of placental genes related to markers
and mediators of inﬂammation and leads to impaired fetal growth and
programming, which causes several metabolic diseases [16].
The goal of our study was to investigate the direct effects of
hyperglycemia on HBCs through in vivo and in vitro systems. We
investigated at mRNA and protein levels, some markers of M2 and M1
macrophages in the placentae from control and type-1 diabetic women.
We also used placentae from rats injectedwith streptozotocin (STZ),
as a model for diabetes, to observe if imbalances in macrophages (with
decreasedHBCs) developed. To study the direct effect of high glucose on
HBCs, we isolated cells from rat placentae and stimulated them with
high glucose in time-course experiments. In vivo and in vitro, HBCs
triggered by hyperglycemia/high glucose damp their M2 proﬁles and
switch towards an M1 proﬁle with increased expression of genes
related to pro-inﬂammatory cytokines and markers.
2. Materials and methods
2.1. Human samples
Placentae (n = 5) were obtained from controls and type-1 diabetic
women (receiving an insulin therapy) in the Hospital of Lille (France).
We veriﬁed that control women had normal glucose tolerance
during their pregnancy. This study was approved by the ethics
committee of the CHRU of Lille under the DIAMANT framework. All
women included received verbal information about the study and
gave their written consent before the analyses. The patients' character-
istics are summarized in Table 1.
2.2. Animals
Three-month-old Wistar rats, on their 5th day of pregnancy, were
purchased from Janvier SAS (Le Genest Saint Isle, France). All animal
experiments respected the conditions established by The European
Communication Council Directive of November 24, 1986 (86/609/
EEC). On the 7th day of gestation, the animals received a single dose
of streptozotocin (STZ; Sigma-Aldrich Chimie, France) (65 mg/kg
dissolved in 0.1 M citrate buffer, pH 4.5) by intraperitoneal injection.
Control animals were injected with the same volume of citrate buffer.
Capillary glycemia (mg/dL) was evaluated daily in both experimental
groups. All animals were sacriﬁced on the 21st day of gestation,Table 1
Patient characteristics.
Patient's
proﬁles
Gestational
weeks
BMI Glycemia 1st
trimester
(mg/dL)
Glycemia 2nd
trimester
(mg/dL)
G
t
(
Control 37.60 ±
0.244
20.52 ±
0.459
79.20 ± 3.056 76.40 ± 1.720 7
Diabetic 37.50 ±
0.500
21.74 ±
1.333
148.6 ± 23.03 167.5 ± 32.76 1
p values p b 0.8529 ns p b 0.4122 ns p b 0.0174⁎ p b 0.0160⁎ p
The table shows mean ± sem of patient characteristics; n = 5 for each group. ns = not signiﬁ
⁎ p b 0.05.corresponding to the end of pregnancy, and placental samples were
collected under sterile conditions.
2.3. Isolation of placental macrophages
Placental membranes were removed and all placentaewerewashed
several times in PBS to eliminate red blood cells. The placentae were
minced in a 37 °C HBSS, supplemented with 1 mg/mL of collagenase
P (Sigma) and left for 40 min at 37 °C in an orbital shaker until the
tissue was completely digested, which was stopped by adding cold
sterile PBS, with 5% BSA and 1% penicillin/streptomycin (P/S, Sigma).
After centrifugation, the pellet was suspended in PBS with 5% BSA, 1%
P/S, and 2-mM EDTA, and passed through a 70-μm nylon cell strainer.
The cell suspension was washed several times and red blood-lysis
buffer (eBioscience) was used to remove the contaminating red blood
cells. Cell counts and viability were evaluated.
2.4. Puriﬁcation of placental macrophages and ﬂow cytometry
Dissociated placental cells were incubated for 1 h at 4 °C with
mouse anti-rat CD163 (AbD Serotec), washed, and then incubated
with anti-mouse IgG microbeads (Miltenyi Biotec) for 15 min at 4 °C
according to the manufacturer's protocol. Puriﬁcation was performed
using an autoMACS separator (Miltenyi), following the manufacturer's
instructions. To assess the purity of HBCs, after a 48-h recovery period,
cells were sequentially stained with mouse anti-rat CD163 (1:1000)
(AbD Serotec) coupled with a secondary IgG1 anti-mouse antibody
labeled with FITC (1:1000) (BioLegend). As a negative control, an
appropriate FITC mouse IgG1 κ isotype (BioLegend) was used
(1:1000). Samples were evaluated on an Accuri C6 Flow Cytometer
(BD Bioscience).
2.5. Cell culture and treatment
MACS-puriﬁed placental macrophages were plated in 48-well
plates, at 5 × 105 cells per well and cultured with RPMI1640 without
glucose, supplemented with 10% FBS, 1% P/S (Sigma), 1% Glutamax,
and 5.5 mM of glucose for a 24 h recovery period. Cells, cultured for
24 h at 5.5 mMof glucose, were considered as 0 h and are representing
the “control” for all time course experiments. After this period, cells
were treated with 25 mM of glucose and culture media: RNAs and
proteins were collected at different time points (0, 2, 6, and 24 h). All
reagents used for the cell-culture experiments were purchased from
Life Technologies.
2.6. RNA extraction and quantitative RT-PCR analysis
Total RNA was extracted using Trizol® Reagent (Life Technologies).
For the placentae, 50 mg of tissue, and for placental macrophages,
5 × 105 cells. 1 μg of total RNA was retro-transcribed in cDNA using
Thermoscript RT-PCR System (Life Technologies). Quantitative RT-PCR
analysis was performed using a Light-cycler 480 SYBR Green I Masterlycemia 3rd
rimester
mg/dL)
HbA1c 1st
trimester
(%)
HbA1c 2nd
trimester
(%)
HbA1c 3rd
trimester
(%)
5.40 ± 1.965 na na na
56.6 ± 27.13 7.32 ± 0.676 6.96 ± 0.524 7.92 ± 0.404
b 0.0175⁎
cant; na = not available; BMI = Body Mass Index; HbA1c = glycated hemoglobin.
Table 2
Primer sequences used for RT-PCR.
Accession number ID name Forward Reverse
NM_000576.2 Hu IL-1b AAACCTCTTCGAGGCACAAG GTTTAGGGCCATCAGCTTCA
NM_000572.2 Hu IL-10 CATCGATTTCTTCCCTGTGAA TCTTGGAGCTTATTAAAGGCATTC
NM_001251.2 Hu CD68 GCTACTGGCAGCCCAGG CGTGAAGGATGGCAGCAAAG
NM_004244.5 Hu CD163 ACTTGAAGACTCTGGATCTGCT CTGGTGACAAAACAGGCACTG
NM_001838.3 Hu CCR7 GGACCTGGGGAAACCAATGA AAAGTTCCGCACGTCCTTCT
NM_021155.3 Hu CD209 AACAGCTGAGAGGCCTTGGA GGGACCATGGCCAAGACA
NM_001017992.3 Hu β actin ACTCCTGCTTGCTGATGCA CATGTACCCAGGCATTGCT
NM_001031638.1 Rat Cd68 ACCTGCTCTCCCTGAGGCTGC CGCAAGAGAAGCATGGCCCG
NM_001107887.1 Rat Cd163 CGGCGTGGTGTGCAGGGAAT GGACCCCAGGCTCCGAGTGT
NM_199489.4 Rat Ccr7 CACTCTGCTCCAGGCGCGAA GGGCCAGGACCACCCCATTG
NM_022611.1 Rat Il12 p40 CCCTGAGTCTCGGGCGGTGA CCTCGGCAGTTGGGCAGGTG
XM_001064643.2 Rat Cd209 TCCAAAGGTGCCCTGCACCAA GTCCCAGGAGCAGGGACGACA
NM_012611.3 Rat Nos2 CGC TACACTTCCAACGCAACA CGGATTCTGGAGGGATTTCA
NM_019178.1 Rat Tlr4 GCTGGTTGCAGAAAATGCCA AGGAAGTACCTCTATGCAGGG
NM_198130.1 Rat Myd88 TGTATGAACTGAAGGACCGC ATGCCTCCCAGTTCCTTTG
NM_198769.2 Rat Tlr2 GGAGGTCTCCAGGTCAAATCT TGTTTGCTGTGAGTCCCGAG
NM_001107754.2 Rat Traf6 CGTGTGCGATCGATTGACTG CTGACACAGCCACTCACACT
NM_001106791.2 Rat Irak4 GCTTGCGCAGAAGCTAGAAC ACTGTGAAATCGAGTGTCGCT
NM_001106586.1 Rat Irf5 CGCAGACAGAGCCCTTTGCCAT CATCCTGGCTGGGACCGTGC
NM_201270.1 Rat Il4 AGCCCCCACCTTGCTGTCAC TCTCCGTGGTGTTCCTTGTTGCC
NM_031512.2 Rat Il1β CACCTCTCAAGCAGAGCACAG GGGTTCCATGGTGAAGTCAAC
NM_138880.2 Rat Infγ ACGCCGCGTCTTGGTTTTGC TCGTGTTACCGTCCTTTTGCCAGT
NM_012854.2 Rat Il10 TGATGCCCCAGGCAGAGAACCA ATCGATGACAGCGTCGCAGC
NM_012675.3 Rat Tnfα CCCACGTCGTAGCAAACCACCA CCATTGGCCAGGAGGGCGTTG
NM_024359.1 Rat Hif-1α TACCCTAACAAGCCGGGGGAGG GCCTGTGCAGTGCAGCACCTTC
NM_012583.2 Rat Hprt ACCTGGGACCGAGACATGTA GAAGATGGTGTGCTCATTGC
Hu = Homo sapiens, Rat = Rattus norvegicus.
1961G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968(Roche Diagnostic, France) on an ABI Prism 7900HT instrument (Life
Technologies). The primers used are listed in Table 2.
The 2−ΔΔCT method was used to analyze gene expression [17].
β actin and Hprt (hypoxanthine phosphoribosyl-transferase) were
used as housekeeping genes for humans and rats, respectively. TheTable 3
Fold change and p values of mRNA expression of genes evaluated in the time course
experiments.
Gene 2 h 6 h 24 h
Fold p value Fold p value Fold p value
TIr2 0.9 ns 1 ns 4.9 ⁎⁎
;##;§§
TIr4 3.9 ns 1.6 ns 12.8 ⁎⁎⁎
;###;§§§
Myd88 2.1 ns 2.5 ⁎ 1 §
Irak4 8.2 ⁎ 5.3 ns 5.2 ns
Traf6 2.6 ⁎⁎ 3.1 ⁎⁎⁎
;##
4.3 ⁎⁎⁎
;§
Irf5 1.3 ns 3.8 ns 9.7 ⁎
;#
Tnfa 2 ns 1.8 ns 7.3 ⁎⁎
;#;§
II12p40 2 ns 2.3 ns 11 ⁎
;#;§
II1β 1.2 ns 1.9 ns 3.5 ⁎⁎
;##
Infy 8.4 ⁎ 12.7 ⁎⁎⁎ 5.4 §
II10 −3.2 ⁎⁎ −4.3 ⁎⁎ −2.3 ⁎
II4 −2 ns −3.5 ns −1.1 ns
Cd163 – – – – −3.9 ⁎
Ccr7 – – – – 3.1 ⁎
Cd209 – – – – −2.2 ⁎
Hif1a 51 ⁎⁎ 7.4 §§ 4.2 ##
Nos2 17.7 ⁎ 6.7 ns 11.1
Fold = fold change over 0 h; ns = not signiﬁcant. *0 h versus all, #2 h versus all, §6 h
versus all.
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
# p b 0.05.
## p b 0.01.
### p b 0.001.
§ p b 0.05.
§§ p b 0.01.
§§§ p b 0.001.calculated fold change and p-values, obtained by evaluating mRNA
expression, are reported in Table 3.
2.7. Immunohistochemistry
Human and rat placentae were ﬁxed in a 4% paraformaldehyde
solution and embedded in parafﬁn. For rats, tissue sectionswere stained
with mouse anti-rat CD163 (1:500 AbD Serotec) and mouse anti-rat
CD68 (1:500, AbD Serotec). For humans, mouse anti-human CD163
(1:500, AbDSerotec) andmouse anti-human CD68 (1:500, eBioscience)
were used. For immunohistochemistry, slides were incubated with
peroxidase-labeled polymer conjugated to goat anti-mouse (EnVision/
HRP, Dako). The chromogenic reaction was carried out with 3,3′-
diaminobenzidine and counterstained with hematoxylin. Because of
using antibodies from the same host species, we proceeded: incubating
with CD163 for 2 h at RT (room temperature), washing for 5 min ﬁve
times, and then incubating with the appropriate secondary antibody
for 1 h at RT, followed by a further ﬁve washes, for 5 min each. This
procedure was then repeated for CD68 staining.
For immunoﬂuorescence, anti-mouse Alexa 594 and anti-mouse
Alexa 488 antibodies (1:1000, Life Technologies) for CD163 and CD68
were used, respectively. Vectashield® Mounting Medium with DAPI
was added to counterstain the nuclei. The slides were analyzed with
inverted ﬂuorescence microscopy and the images captured with an
Axiocam (Zeiss). For cell counts, we analyzed by ImageJ (NIH) the
human and rat placenta slides stained with CD163 (green), CD68
(red) and Dapi for the nuclei (blue) and we determined the ratio of
the cells positive for CD163 on CD68. Normalization has been done by
counting the total number of nuclei.
2.8. NFkB translocation
Sorted HBCs were grown on chamber glass slides coated with poly-
lysine (Sigma). Cells were treatedwith 25 mMof glucose for 0, 2, 6, and
24 h. Cells were ﬁxed with 4% paraformaldehyde solution and perme-
abilized with PBS plus 0.3% Triton X-100 (Sigma). After washing,
protein block solution (Dako) was added and the cells were incubated
1962 G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968overnight at 4 °C with rabbit anti-NFkB p65 (1:500; eBioscience). The
cells were then washed and incubated with anti-rabbit Alexa 488 (Life
Technologies), 1:1000, for 1 h at room temperature. After washing,
Vectashield® Mounting Medium with DAPI was added to stain the
nuclei. The cells were analyzed by inverted ﬂuorescence microscopy
and the images were captured with an Axiocam (Zeiss).
2.9. Western blot
Tissue and cellular lysates were resolved by 10% SDS-PAGE and
transferred to a nitrocellulose membrane. The antibodies used were
mouse anti-human CD68, 1:1000 (eBioscience), mouse anti-human
CD163 1:1000 (AbD Serotec), mouse anti-rat Traf6 1:1000 (AbD
Serotec), and mouse anti-β-actin (Sigma) 1:5000. IRDye secondary
antibodies: 800CW anti-mouse, and 680RD anti-rabbit (LI-COR
Biosciences) were used at 1:15,000. The membranes were scanned for
infrared signals by an Odyssey Imaging System (LI-COR Biosciences).
Densitometry analysis was performed using ImageJ.
2.10. Cytokine ELISA and NO measurements
Themedia, collected during the time-course experiments,were used
for semi-quantitative analyses of rat chemokines and cytokines released
using a Multi-Analyte ELISArray kit (SABiosciences). Each value of
absorbance, measured at 450 nm and corrected at 570 nm, was
normalized with hprt expression. Values are indicated as arbitrary
units. The culturemediawere also submitted to nitrite (NO) determina-
tion using the Griess method, with readings taken at 540 nm.Fig. 1. Analysis of macrophage marker expression in control and diabetic human placentae. Ana
were selected as representativemarkers ofM2macrophages, and CD68, CCR7, and IL1β asmark
sion of M2 genes whereas, in diabetic placentae, M1markers are increased. Data are expressed
performed using ANOVAwith a Bonferroni correction, *p b 0.05. (A). Immunoblots with anti-C
trol and diabetic placentae: in diabetics, protein CD68 level increasedwhile CD163 decreased si
means ± SEMs. Student t-test was used for the statistical analyses, *p b 0.05; **p b 0.01. (B). I
and [D] were performed using anti-CD163 (red) and anti-CD68 (green); nuclei were stained wi
are means ± SEMs of 3 experiments, *p b 0.05, Student's t-test (D).2.11. Statistical analyses
Data are expressed as theirmeans ± SEMs. Statistical analyses were
performed using the two-tailed paired Student's t-test and ANOVA,
followed by a Bonferroni correction. A p-value b0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Placental expression of markers related toM2macrophages decrease in
diabetic human placentae
Human placentae from control and diabetic patients were used to
analyze the mRNA expression of genes related to M2 and M1
macrophages (Fig. 1A). For M2, we analyzed the expression of CD163,
a marker of HBCs, CD209, and Il10 (interleukin 10). When comparing
diabetics versus controls, we noticed that there was a sustained
tendency (but not signiﬁcant) for decreased CD163 (p b 0.0548). For
CD209 and Il10, the decreases were signiﬁcant (p b 0.05) for both
genes.
For M1 macrophages, CD68, Il1β (interleukin 1 beta), and CCR7
(chemokine receptor 7) were analyzed. For CD68 and Il1β, expression
was signiﬁcantly higher in diabetics versus controls (p b 0.05 for CD68
and p b 0.01 for Il1β); there was also a tendency for CCR7 to increase
(p b 0.078).
Regarding protein level, we investigated the expression of CD68 and
CD163 by western blot analyses in control and diabetic placentae
(Fig. 1B). In diabetics, we observed a signiﬁcant increase in CD68lysis of mRNA expression in control C versus diabetic D placentae. CD163, CD209, and IL10
ers forM1macrophages. Placentae from control patients are characterized by high expres-
asmeans ± SEMs and represent 5 samples analyzed in duplicate. Statistical analyses were
D68, anti-CD163, and anti-b actin were performed on proteins extracted from human con-
gniﬁcantly. Images and data are representative of 3 independent experiments expressed as
mmunoﬂuorescence analyses of human placentae in parafﬁn-embedded sections from [C]
th DAPI (blue) (C). Ratio of CD163/CD68 positive cells was evaluated by cell count. Results
1963G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968(p b 0.05) and a signiﬁcant decrease in CD163 (p b 0.01)Weperformed
immunoﬂuorescence analyses on control and diabetic human placentae
using CD163 as amarker for HBCs, and CD68 as a generalmarker for M1
macrophages (Fig. 1C). We performed the cell count of CD163 and
CD68-positive cells, expressed it as ratio of CD163/CD68 andwe noticed
an imbalance between the two markers. In control placentae, HBCs
were clearly the most representative population of macrophages
whereas, in diabetic placentae, we found the opposite, a signiﬁcant
decrease of the ratio (p b 0.05) (Fig. 1D).
3.2. Placental expression of markers related toM2macrophages decrease in
rat model of diabetes
Pregnant Wistar rats were injected with STZ to mimic the diabetes
that occurs during human pregnancy [18]. High values of blood glucose
were recorded throughout the rats' pregnancy, conﬁrming their
diabetic status (Fig. 2A). The expressions of CD163 and CD68 were
analyzed in the placentae from STZ-treated and control rats. In STZ
placentae, we observed a signiﬁcant decrease in CD163 (p b 0.05) and
a signiﬁcant increase in the expression of CD68 (p b 0.05; Fig. 2B).
Stained parafﬁn sections of STZ and control placentae (Fig. 2C) revealed
a reduced number of HBCs in STZ placentae compared to controls.
We performed immunoﬂuorescence staining with CD163 and CD68
antibodies in control and STZ placentae (Fig. 2D). The number of HBC
cells positive for CD163 was decreased in placentae from STZ animals,
whereas the number of macrophages positive for CD68 was increased,
with a decreased ratio of CD163/CD68 (p b 0.05) obtained by cellFig. 2. Analysis of macrophage marker expression in control and streptozotocin-treated rat plac
values of glycemia (mg/dL)monitored during the gestation periodwere signiﬁcantly higher in S
***p b 0.001; ANOVA with a Bonferroni correction. mRNA expression of CD163 and CD68 in co
representative of 3 independent experiments analyzed in duplicate. Immunohistochemistry of
tibodywas omitted (C). Immunoﬂuorescence analyses of placenta sections from the control and
stainedwith DAPI (blue) (D). Ratio of CD163/CD68 positive cells was evaluated by cell count, re
cence on isolated rat placental cells. HBCswere stainedwith CD163 (red); DAPI (blue)was used
cytometric histogram analyses of HBCs after the puriﬁcation step. We obtained a purity of 89.4counting (Fig. 2E). Our results indicate that hyperglycemia, induced by
injecting STZ during pregnancy, reduced the number of placental
macrophages with a M2 proﬁle while, at the same time, increasing
those with a M1 proﬁle.
3.3. High glucose induces the expression of genes related to the TLRs'
inﬂammation-signaling pathway in isolated HBCs
We established an in vitromodel of isolated rat HBCs to determine if
increased M1 macrophage markers in diabetic placentae were caused
by recruitment of macrophages that were already M1-polarized or
because of a switch from M2 to a M1 proﬁle.
We cultured HBCs in high-glucose conditions (25 mM) at different
time points. As shown in Fig. 2F, we dissociated cells from rat placenta
on the 21st day of pregnancy and stained them for CD163 antibodies.
After magnetic sorting, we obtained a pure population of CD163-
positive cells (purity: 89.86% ±1.46; Fig. 2F, lower panel). Cells were
cultured for a 24 h recovery period with RPMI 1640 supplemented
with 5.5-mM glucose. After this period, the cells were challenged with
25 mM of glucose for 0, 2, 6, and 24 h, and mRNA was extracted to
analyze the expression of genes implicated in the inﬂammatory
activation pathway mediated by Tlr–Myd88–Traf6's axis.
High glucose treatment did not have an osmolarity effect, as
previously shown in several studies using different concentrations of
mannitol on cultured macrophages [19,20]. Various studies have
already reported that high-glucose treatment induces an increased
expression and activity of Tlr4 and Tlr2 in THP-1 cells. The same increaseentae. Wistar rats were injected on the 7th day of gestation with STZ (streptozotocin). The
TZ vs. the controls C (A). Results are themeans ± SEMs of three independent experiments;
ntrols and STZ total placentae using real-time PCR (B). Student's t-test; *p b 0.05. Data are
the control and STZ rat placentae with CD163 (brown). For the negative [Neg], CD163 an-
STZ animals were performed using anti-CD163 (red) and anti-CD68 (green); nuclei were
sults are means ± SEMs of 3 experiments, *p b 0.05, Student's t-test (E). Immunoﬂuores-
to counterstain the nuclei. Pictures are representative of 3 independent experiments. Flow
6 ± 1.46. Results are the means ± SEMs of 3 experiments (F).
Fig. 4. Traf6 expression inHBCs treatedwith high glucose in time-course experiments. Im-
munoblot with anti-Traf6 and anti-b actin antibodies was performed on protein extracts
from the time-course experiments on HBCs. The western-blot image is representative of
3 independent experiments. Mean optical densitometric data of Traf6. Protein was signif-
icantly increased after 2 h and after 24 h. Data are representative of 3 independent exper-
iments expressed as their means ± SEMs. Statistical analyses was performed by an
ANOVA with a Bonferroni correction, *p b 0.05, 0 h vs. all.
1964 G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968has been reported for the adapter molecule Myd88, resulting in the
activation of Traf6, NFkB [20], and Irf5 [21]. This pathway leads to the
expression of pro-inﬂammatory molecules.
In our time-course experiments (Fig. 3), Tlr2 expression increased
almost 5-fold (p b 0.01) and Tlr4 by 12-fold (p b 0.001) after 24 h.
The expression of the Tlrs family adapter, Myd88, increased 2.5-fold
(p b 0.05) after 6 h, and returned to its basal expression level after 24 h.
Myd88 interacts with IRAK4, and the MyD88/IRAK4 complex
recruits the IRAK4 substrate IRAK2 or IRAK1. This complex elicits the
activation of a phosphorylation cascade [22]. We observed increased
expression of Irak4 throughout the time course, which reached an 8-
fold induction after 2 h (p b 0.05). MyD88 recruits IRAK4, and then
Traf6 (Tnf receptor-associated factor 6) [23].
We noticed a signiﬁcant increase in Traf6 mRNA during the entire
time course, with 2.5-, 3- and 4-fold changes at 2, 6, and 24 h,
espectively. We also conﬁrmed an increased protein level of Traf6
(Fig. 4). We focused on transcription factor Irf5 (interferon regulatory
factor 5), which is activated by the molecular complex consisting of
IRAK4 and TRAF6 [24]. IRF-5 has an essential role in the antiviral and in-
ﬂammatory responses. Mice knockout IRF5 show a defect not only in
the induction of IFN but also in the expression of TNFα, IL-12, and IL-6
[25,26]. The expression of Irf5 in HBCs treatedwith high glucosewas in-
creased in a time-dependentmanner, and reached an almost 10-fold in-
crease (p b 0.05) after 24 h (Fig. 3).Fig. 3. Analyses of TLR's inﬂammatory pathway by mRNA expression in HBCs treated with high glucose in time-course experiments. Time-course mRNA expression of Tlr2, Tlr4, Myd88,
Irak4, Traf6, and Irf5 by real-time PCR on HBCs stimulated with 25-mM glucose. Values are means ± SEMs of the fold change compared to 0 h (baseline). Data are representative of 3–4
independent experiments analyzed in duplicate. Statistical analyses were performed using ANOVA with a Bonferroni correction.*0 h vs. all; #2 h vs. all; § 6 h vs. all.
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NFκB activation involves phosphorylation, ubiquitination, and
proteolytic degradation of IκB-α, which releases the p50/65 active
dimer of NFκB and moves from the cytoplasm to the nucleus. Thus,
high glucose induces activation of NFκB by a Myd88-dependent
pathway [27].
We performed immunoﬂuorescence analyses on NFκB translocation
inHBCs challengedwith 25 mMof glucose.Wedetermined that nuclear
localization (blue) of NFκB (green) started after only 2 h of exposure to
high glucose, and reached a maximum nuclear translocation at 24 h
(Fig. 5).3.5. High glucose induces expression of pro-inﬂammatory cytokines and
markers in RNA and protein levels in isolated HBCs
We evaluated the effects of high glucose on gene expression of pro-
and anti-inﬂammatory cytokines and markers. The gene expression of
Tnfα and the p40 subunit of IL-12 (IL-12b), both transcriptionally
under the control of Irf5 [28], increased 7-fold (p b 0.05) and almost
11-fold (p b 0.05), respectively, after 24 h (Fig. 6A). We also analyzed
the gene expression of other pro-inﬂammatory cytokines under the
control of NFκB: Il1β [29] and Infγ [30]. For Il1β, we obtained a 3.5-
fold increase (p b 0.01) after 24 h. For Infγ, we observed an 8-fold
increase (p b 0.05) after 2 h, which peaked at 12-fold after 6 h
(p b 0.01); however, after 24 h, values decreased (Fig. 6A). In contrast,
we examined the expression of Il10, a typical anti-inﬂammatory
cytokine. The expression of Il10 decreased signiﬁcantly during the
time-course experiments, especially after 2 h, with a 3-fold change
(p b 0.01) and a 4-fold change after 6 h (p b 0.01; Fig. 6B). Previously
published papers report that Irf5 has an inhibitory effect on the
transcription of Il10 [28].We determined the expression ofM2markers,
such as CD163 [31] and CD209 (DC-SIGN) [32], at 0 h and after 24 h of
high glucose stimulation. We observed a decrease in both genes
(p b 0.05), of −4-fold and −2-fold, respectively (Fig. 6C). In contrast,
we observed a signiﬁcant increase (3-fold, p b 0.05) of Ccr7, an M1
marker [33], after 24 h versus 0 h (Fig. 6C).
We evaluated if high glucose treatment affected the secretion of pro-
and anti-inﬂammatory cytokines. We harvested the media at 0 h and
24 h after the high-glucose challenge, and performed a semi-
quantitative analysis on the cytokines/chemokines released using an
ELISA multi-analyte kit (Fig. 7A). We observed that, protein levels of
Il1β and Il10 had the same signiﬁcant tendency at 0 h and 24 h as
that of mRNA levels. As we observed at the mRNA level that the
expression of Infγ peaked between 2 h and 6 h and decreased at 24 h,
we compared the cell media at 2 h and 24 h to see if the same trend
occurred at the protein level. Infγ, released into the culture media,
decreased at 24 h compared to 2 h (p b 0.01) (Fig. 7B).Fig. 5. NFkB nuclear translocation. Immunoﬂuorescence analysis of NFkB p65 translocation in r
were stainedwith NFkB p65 (green) and nuclei were stainedwith DAPI (blue). Pictures were ta
experiments.3.6. High-glucose treatment induces the expression of Hif1-α and increases
NO production
Hif1-α (hypoxia inducible factor 1α) is a typical transcription factor
induced during hypoxia. It has been already shown that the expression
of Hif1-α increases via activation of the Tlr4–Myd88–Nfkb pathway in
myeloid cells exposed to inﬂammatory stimuli in normoxia condi-
tions [34]. Moreover, Hif1-α is induced by high glucose [35]. We inves-
tigated the expression of the Hif1-α gene in HBCs treated with high
glucose. As shown in Fig. 8A, we obtained a 17-fold increase after 2 h
(p b 0.01). One of Hif1-α's target genes isNos2 (inducible NO synthase),
which is highly expressed by M1 polarized macrophages [36]. We
observed a 5-fold increase in Nos2 mRNA after 2 h (p b 0.05; Fig. 8B).
Increased Nos2 leads to intensify NO (nitric oxide) production. We
assessed NO release into the culture media and observed a 4-fold
increase (p b 0.05) after 24 h (Fig. 8C).
4. Discussion
Diabetes affects fetal development and increases the risk of met-
abolic disorders in adulthood. The detrimental effects of diabetes on
the human placenta elicit strong changes in the expression of
inﬂammation-related genes [16]. Placental macrophages, together
with other components of the immune system, play a crucial role
in maintaining an immuno-suppressive state, characterized by
immune modulation of anti-inﬂammatory molecules. Placental
macrophages can be classiﬁed as alternative activated macrophages
(M2) [37]. In particular, HBCs have been identiﬁed as placental mac-
rophages of fetal origin: they are classiﬁed as M2 and express as
CD163 [32].
We observed that diabetes during pregnancy, in both human and rat
models, increased the imbalance between anti- and pro-inﬂammatory
macrophages. We investigated if this imbalance was caused by an
increase in M1 macrophages (newly recruited) or to a change from
M2 to a M1 phenotype. In this study, for the ﬁrst time, we show that,
in vitro, rat isolated HBCs, under high glucose condition (mimicking
hyperglycemia in diabetes) for a short time, resulted in a change from
havingM2 characteristics to acquiring a pro-inﬂammatory proﬁle (M1).
We ﬁrst focused on themRNA expression of TLRs and some partners
within their activation pathway. We observed that high glucose, in a
time-dependent manner, triggered increased expression of Tlr2, Tlr4,
and their downstream molecules, Myd88, Irak4, Traf6, and the
transcription factor IRF5. Using immunoﬂuorescence, during the time-
course experiments, we conﬁrmed the activation of NFκBs in response
to high glucose p65 subunit nuclear translocation. Activation of the
TLR pathway ends with the transcription factors, IRF5 and NFkB, and
favors pro-inﬂammatory cytokine expression [38].
We also investigated the expression of several pro- and anti-
inﬂammatory cytokines, including Tnfα, Il12p40, Infγ, Il1β, Il10, andesponse to 25 mM of glucose during the time-course experiment on HBCs. Hofbauer cells
ken with an inverted ﬂuorescentmicroscope. Pictures are representative of 3 independent
Fig. 6. Analysis ofmRNA expression of cytokine andmacrophagemarkers in time-course experiments. Analysis ofmRNA expression of pro-inﬂammatory cytokines: Il12p40, Tnf, Il1β, and
Infγ during time-course experiments of HBCs treated with 25 mM of glucose (A). Analysis of mRNA expression of the anti-inﬂammatory cytokines, II4 and Il10, during time-course ex-
periments of HBCs treated with 25 mM of glucose (B). Analysis of mRNA expression of anti- and pro-inﬂammatory markers CD163, CD209, and Ccr7 at 0 h and 24 h of the time-course
experiments (C). Values are the means ± SEMs of fold change compared to 0 h (baseline). The data are representative of 3 independent experiments analyzed in duplicate. Statistical
analyses were performed using ANOVA with a Bonferroni correction. *0 h vs. all; # 2 h vs. all; § 6 h vs. all. For panel (C), Student's t-test was used: *p b 0.05; **p b 0.01; ***p b 0.001.
1966 G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968Il4, and some macrophage markers, CD163, Ccr7, and CD209. We
observed an increase in pro-inﬂammatory markers and cytokines at
mRNA and protein levels, whereas anti-inﬂammatory molecules were
decreased.
We found that there was an increased release of NO in the media
during high-glucose treatments. Related to this, we found, regarding
mRNA levels, increased expression of NOS2 and one of its transcription
factor Hif1-α. Tlr2 and Tlr4 belong to Toll-Like Receptor family and
share, with the other members of this family, the ability to induce
pathways involving the innate immune response to external stimuli. A
previous study has already demonstrated that these two receptors are
activated in human monocytes by high glucose [20].
The downstream genes transcribed in response to Tlr's activation
are known to be pro-inﬂammatory markers and cytokines. IsolatedHBCs from rats at 0 h expressed all the speciﬁc markers of the M2
population, according to mRNA and protein levels. After a few
hours of treatment, because of the activation of the Tlr axis, HBCs
started to express M1 markers and to release pro-inﬂammatory
cytokines. Once high glucose ignites the cascade, this leads to the
release of pro-inﬂammatory cytokines, which can potentiate, by
canonical ways, the inﬂammatory cascade. Despite the fact that
HBCs, at the time of isolation, were already polarized as M2, they
could, in vitro, under high-glucose conditions, switch from an M2
to a M1 proﬁle.
Macrophages, classiﬁed as M1 or M2, are the result of differentia-
tion of bone marrow precursors, which is driven by environmental
signals. These precursors maintain a kind of adaptive plasticity [39]. In
support of our hypothesis, some studies suggest that mature-tissue
Fig. 7. Cytokines released into culture media by HBCs treated with high glucose. Culture media from puriﬁed CD163-positive cells treated with 25 mM of glucose at 0 h vs. 24 h were
harvested, and chemokines and cytokines were evaluated by ELISA (A). The measurement of Ifnγ, released into the media, was performed at 2 h vs. 24 h to conﬁrm the data obtained
formRNA level during the time-course experiments (B). Datawere normalized toHprt expression and expressed as arbitrary units (AU). *p b 0.05, vs. 24 h, and 2 h vs. 24 hwith Student's
t-test.
1967G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968macrophages, in response to environmental factors, can also progres-
sively shift their functional phenotype in a reversible adaptive way
[40]. We could assume that the shift from the M2 to the M1 proﬁle,
which we observed in vitro and in vivo, involve another higher level
of communication between environmental stimuli and cell responses,
such as epigenetic modiﬁcations.
A study has recently shown that high glucose can activate multiple
chromatin markers in THP-1 cell lines and blood monocytes [41]. In
support of this, we observed a signiﬁcant increase in the expression of
de novo DNA methyltransferase 3 (Dnmt3) after 24 h of treatment
(data not shown).Fig. 8. Pathway leading to nitrite production during the time-course experiments. HBCs isolated
by real-time PCR, ofmRNA expression of Hif1α andNos2 (A) and (B) respectively. The culturem
NO production was measured using Griess' method (C). Values are the means ± SEMs of th
experiments analyzed in duplicate. Statistical analyses were performed using ANOVAwith a BoIn conclusion,we observed that diabetes/hyperglycemia, in vivo and
in vitro, led to decreased HBC characteristics and increased pro-
inﬂammatory macrophages. Thus, we hypothesize that these cells,
in vivo, could reverse their functional phenotype, and contribute to
the detrimental inﬂammation status of the placenta and result in
negative consequences to the fetal environment.
Our current understanding of maternal diabetes-induced changes in
pro-inﬂammatory and anti-inﬂammatory pathways that affect placen-
tal development highlights the need for strict maternal control of
glycemia to prevent deleterious consequences to the offspring. In the
context of placental inﬂammation status caused by diabetes, we couldfrom the placentaewere treated at different time points with 25 mMof glucose. Analyses,
edia fromHBCs treatedwith 25 mMof glucose at different time pointswere harvested and
e fold change compared to 0 h (baseline). The data are representative of 3 independent
nferroni correction. *0 h vs. all; #2 h vs. all; §6 h vs. all. *p b 0.05; **p b 0.01; ***p b 0.001.
1968 G. Sisino et al. / Biochimica et Biophysica Acta 1832 (2013) 1959–1968suggest a therapeutic strategy that focuses on damping the shift from
M2 toM1 targeting one of the actors within the Tlr-activation pathway.Acknowledgements
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